passages.id: split_6_test_173_passage
passages.type: progene_text
passages.text: MSF produced a mean of 89.5 % inhibition of erythrocyte AChE in patients and improved cognitive performance as measured by the MMSE , Alzheimer Disease Assessment Scale-Cognitive Subscale ( ADAS-COG ) , Global Deterioration Scale , and the Clinical Interview Based Impression of Change ( CIBIC ) .